Focus:
News
-
3 July 2020
India approves second Covid-19 vaccine for clinical trials
Zydus Cadila has secured regulatory approval from the Drug Controller General of India (DCGI) to conduct Phase I/II human trials of its Covid-19 vaccine candidate, named ZyCoV-D.
-
3 July 2020
Sanofi and Regeneron’s Kevzara fails in Phase III Covid-19 trial
Sanofi and Regeneron Pharmaceuticals have reported that a Phase III clinical trial of rheumatoid arthritis drug Kevzara (sarilumab) failed to meet its primary and key secondary endpoints in Covid-19 patients...
-
2 July 2020
EUSA Pharma wins FDA approval for trial of siltuximab to treat ARDS
EUSA Pharma has secured approval from the US Food & Drug Administration (FDA) for a Phase III clinical trial protocol of intravenous siltuximab plus standard of care in hospitalised patients...
-
2 July 2020
IQVIA and LMC Manna Research to launch Prime Site in Canada
IQVIA has entered a strategic alliance with LMC Manna Research to launch its first Prime Site for clinical investigation in Canada.
-
2 July 2020
First Covid-19 vaccine candidate trial begins in Australia
The first clinical trials of a Covid-19 vaccine developed in Australia have commenced at Royal Adelaide Hospital's PARC Clinical Research facility.
-
2 July 2020
Anavex starts dosing patients in Rett syndrome trial
Anavex Life Sciences has dosed the first patient in the Phase II/III EXCELLENCE clinical trial of ANAVEX 2-73 (blarcamesine) for the treatment of Rett syndrome.
-
2 July 2020
COVID-19 vaccine could be approved and available to public within six months: Poll
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease
-
2 July 2020
Pfizer-BioNTech’s Covid-19 vaccine candidate yields positive data
Pfizer and BioNTech have reported positive preliminary results from the ongoing Phase I/II clinical trial of BNT162b1, a potential Covid-19 vaccine.
-
1 July 2020
Stanford researchers to assess favipiravir in Covid-19 outpatients
Researchers at Stanford Medicine in the US are starting a clinical trial to evaluate oral favipiravir for reducing symptoms and viral shedding in people with Covid-19.
-
1 July 2020
Eisai to investigate eritoran in REMAP-COVID study
Eisai, in alliance with the Global Coalition for Adaptive Research (GCAR) and University of Pittsburgh Medical Center (UPMC), is set to join the REMAP-COVID study designed to assess various treatments...